Literature DB >> 2981442

Cyclosporine-associated central nervous system toxicity after renal transplantation.

H Wilczek, O Ringden, G Tyden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2981442     DOI： 10.1097/00007890-198501000-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.

Authors:  Chieko Nakahara; Naoyuki Hasegawa; Isho Izumi; Katsuyosi Kanemoto; Nobuaki Iwasaki
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

3.  Renal handling of magnesium in transplanted children under cyclosporin A treatment.

Authors:  F Krull; P F Hoyer; G Offner; J Brodehl
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

4.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 5.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  Complex partial status epilepticus associated with cyclosporin A therapy.

Authors:  R E Appleton; K Farrell; P Teal; S A Hashimoto; P K Wong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

7.  Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

Review 8.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 9.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.